10/9/2024, 1:59:03 pm

Is Hims & Hers Health Stock a Buy?

Telehealth company Hims & Hers Health (NYSE: HIMS) has been great for investors this year by almost any standard; share prices have nearly doubled from a year ago. Yet shareholders aren't feeling the joy. The stock is down nearly 45% since peaking in June, and the negative momentum is weighing on investors. The market is suddenly questioning whether the company can succeed.